Production (Stage)
Sagimet Biosciences Inc.
SGMT
$3.55
$0.051.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.42% | -0.81% | -8.35% | -14.11% | 104.12% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -42.04% | -75.31% | 1,632.66% | -63.42% | -49.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 91.79% | 13.76% | 213.08% | 20.37% | -72.80% |
| Total Current Assets | -4.39% | -2.81% | -5.73% | -14.26% | 101.24% |
|
|
|||||
| Total Current Assets | -4.39% | -2.81% | -5.73% | -14.26% | 101.24% |
| Net Property, Plant & Equipment | -50.65% | -32.46% | -24.50% | 308.11% | -49.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -8.79% | -8.31% | -7.54% | -2.83% | 101.13% |
|
|
|||||
| Total Accounts Payable | 126.18% | 23.70% | -42.23% | 275.52% | 185.48% |
| Total Accrued Expenses | 30.86% | 4.73% | -21.23% | -9.66% | -18.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -50.00% | -32.76% | -24.18% | 488.46% | -60.00% |
| Total Finance Division Other Current Liabilities | 1,160.00% | -54.55% | 10.00% | -- | -- |
| Total Other Current Liabilities | 1,160.00% | -54.55% | 10.00% | -- | -- |
| Total Current Liabilities | 61.20% | 8.85% | -28.56% | 27.01% | -20.23% |
|
|
|||||
| Total Current Liabilities | 61.20% | 8.85% | -28.56% | 27.01% | -20.23% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.20% | 8.85% | -28.56% | 27.01% | -20.23% |
|
|
|||||
| Common Stock & APIC | 0.33% | 0.34% | 0.35% | 0.32% | 30.99% |
| Retained Earnings | -6.15% | -5.80% | -5.53% | -3.17% | -2.65% |
| Treasury Stock & Other | -47.39% | -47.85% | 2,017.39% | -428.57% | -76.67% |
| Total Common Equity | -10.79% | -8.72% | -6.88% | -3.54% | 108.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.79% | -8.72% | -6.88% | -3.54% | 108.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.79% | -8.72% | -6.88% | -3.54% | 108.66% |
|
|
|||||